Dr David Béchard, 36 – Founder, President, COO
10 years of entrepreneurial experience (Endotis Pharma, LSO) and finance/strategy consulting (OC&C Strategy) in biotech-pharma / private equity.
PhD in Immunology-Oncology (Inserm / Pasteur Institute) and 3rd cycle in strategy/finance (HEC Paris).
Vice-President of the BoD of the pole of competitiveness Atlanpole Biotherapy.
Dr Yannick Jacques, 60 – Founder, CSO
35 years of experience in academic research (CNRS, INSERM).
Director of the Cancer Research Center of Nantes-Angers (INSERM U892), University of Nantes, CHU Hotel Dieu.
Polytechnician, PhD in Chemistry-Biology.
Dr Didier Coquoz , 50, CDO/BD&L
20 years of experience in therapies and biotech companies development on both sides of the Atlantic, involved in the development of 24 drugs from lead up to and including registration.
Serial entrepreneur with large pharma/finance network.
PhD in clinical pharmacology (Geneva Medicine Faculty), Pharm D (Geneva Sciences Faculty).
Dr Guy de Martynoff, 53, CTO
20 years of experience in biopharmaceutical production (Innogenetics, Bioprotein, Meristem Therapeutics, DMS biotechnology).
PhD in Chemistry-Molecular Biology (Free University Brussels) with 2 post-doctorates (GSK Bio, Rixensart-BE and E.M.B.L., Heidelberg-DE).
Remora Partners (Switzerland), M&A, BD&L, support
Institute Gustave Roussy (Villejuif), European Hospital Pompidou (Paris), Cancer Research centers (Nantes & Montpellier), SCIENTIFIC ADVISORY BOARD MEMBERS